The potential of cord blood stem cells to reduce neuroinflammation

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cerebral palsy (CP) is the most common cause of physical disability in children and it is well recognised that the brain injury that underlies CP occurs during pregnancy or around the time of birth. Stem cells isolated from umbilical cord blood offer a promising new therapy for children with CP. This proposal will explore the mechanism of how cord blood stem cells can reduce brain inflammation and damage caused by hypoxia-ischemia, an event known to lead to cerebral palsy.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $314,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Foetal Development and Medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cerebral palsy | cord blood | hypoxic-ischaemic encephalopathy | neuroimmunology | stem cell therapy